Dermatoscopy in Clinical Practice: Role in Early Diagnosis of Melanoma and Other Skin Neoplasms

Dermatoscopy, also known as dermoscopy or epiluminescence microscopy, has revolutionized the field of dermatology by significantly improving the early detection and differential diagnosis of melanocytic and non-melanocytic skin tumors. Traditional naked-eye examination of skin lesions is often limited by subjectivity and low sensitivity in identifying early malignancies, particularly in clinically equivocal or atypical presentations. Dermatoscopy overcomes these limitations by providing enhanced visualization of subsurface morphological features such as pigment networks, vascular patterns, globules, streaks, and regression structures that are invisible to the unaided eye. In the context of malignant melanoma, early dermatoscopic identification of asymmetry, multicolor structures, atypical pigment distribution, and blue-white veils allows for prompt excision at a curable stage, thereby reducing morbidity and improving survival rates. Similarly, basal cell carcinoma and squamous cell carcinoma exhibit distinct dermatoscopic criteria—such as arborizing vessels, leaf-like areas, and keratin masses—that facilitate early and accurate diagnosis. Beyond malignant lesions, dermatoscopy aids in distinguishing benign conditions like seborrheic keratosis, dermatofibroma, and angiomas, thus reducing unnecessary biopsies and surgical interventions. The implementation of structured diagnostic algorithms such as the ABCD rule, Menzies method, the 7-point checklist, and the chaos and clues algorithm enhances diagnostic consistency and training efficacy among clinicians. Furthermore, the advent of digital dermatoscopy and AI-assisted image analysis has led to automated lesion classification systems with high sensitivity and specificity, enabling scalable screening programs and decision support in primary care or underserved settings. Teledermatology platforms incorporating dermatoscopic image transmission now enable remote expert consultations and follow-up monitoring for patients with numerous or evolving lesions, including those with a history of skin cancer. Despite technological advances, clinical expertise remains essential for interpretation, especially in ambiguous or atypical presentations.